revealed that circPARD3, a unique autophagy inhibitor, promotes the progression and chemoresistance of laryngeal squamous cell carcinoma via the PRKCI-Akt-mTOR axis. The gene discussed is PRKCI; the disease is laryngeal squamous cell carcinoma.